-
Novo Nordisk names Maziar Mike Doustdar as new CEO
Mike Doustdar is currently serving as the executive vice president of the company's international operation and will succeed Lars Fruergaard Jorgensen who decided to step down from the top post in May this year.
-
Obesity drugmaker Novo Nordisk plunges as it cuts forecasts again
-
SB43154 drug used in cancer research shows promise against COVID-19 in preclinical studies: Scientists
-
Sarepta resumes shipping of gene therapy Elevidys to patients who can walk
-
Torrent Pharmaceuticals plans Semaglutide rollout post patent expiry
Advertisement
Advertisement
